Showing results (381-390 of 884) with videos related to
Sort By:
Pageof 89
Gastroenterology|October 16, 2012
Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysisSiddharth Singh, Preet Paul Singh, Abha Goyal Singh, et al.The American Journal of Gastroenterology|June 25, 2014
Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysisSiddharth Singh, Preet Paul Singh, Mohammad Hassan Murad, et al.Gastroenterology|January 10, 2002
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurineGerald A Dayharsh, Edward V Loftus, William J Sandborn, et al.Inflammatory Bowel Diseases|February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID RegistryEdward V Loftus, Walter Reinisch, Remo Panaccione, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 28, 2010
Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's diseaseBasil S Nasir, Eric J Dozois, Robert R Cima, et al.Gut|January 22, 2013
Geographical variability and environmental risk factors in inflammatory bowel diseaseSiew C Ng, Charles N Bernstein, Morten H Vatn, et al.Inflammatory Bowel Diseases|May 11, 2013
Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitisSunil Samuel, Steven B Ingle, Shamina Dhillon, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019June Tome, Kanika Sehgal, Amrit K Kamboj, et al.Advances in Therapy|November 28, 2025
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy ParticipantsYuki Otani, Christopher D Payne, Edward V Loftus, et al.Crohn'S & Colitis 360|August 28, 2023
Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE StudiesWilliam J Sandborn, Jingjing Chen, Krisztina Kisfalvi, et al.Pageof 89